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Abstract 
Screening mammograph.y identifies suspicious, non palpable mammary lesions. Mammographic
needle localization (MNL) is currently being used to facilitate excision biopsy of these lesions. Thirty-
two patients underwent biopsies of the breast after MNL for non-palpable lesions. Mammographic
indications for biopsy consisted of microcalcifications (48%), mass or abnormal density (21%) or
mass+abnormal density (24%). The carcinoma was identified in four cases (12%). Two of these were in
situ, one was microinvasive and one was frankly invasive. Three were treated with a modified radical
mastectomy. One of these non palpable lesion demonstrated nodal metastasis but none showed distant
metastasis. All radiologically detected abnormalities were removed and confirmed with repeat
radiology. No complications were identified. MNL effectively localizes non- palpable lesion of the
breast and compliments accurate diagnosis and treatment of early carcinoma of the breast (JPMA 46:
149, 1996).
Introduction 
Carcinoma of the breast diagnosed at screening mammography has been shown to have a better overall
prognosis than those diagnosed by physical examination only1,2. In 1973 non-palpable carcinoma of
the breast were shown to be associated with a survival rate superior to that of palpable carcinoma of the
breast and a lower rate of axillary metastasis3. Improved overall stir’ival of women with mam-
mographically detected early carcinoma of the breast has reappraised mammography and its use in
early detection1-3.
However, biopsy of occult lesions was cumbersome and highly inaccurate. Non-invasive methods of
localization such as skin marking or blind biopsy without an attempt at pre-operative localization were
often unsuccessful. Likewise invasive methods using water soluble mentgenographic contrast agents or
vital dyes largely proved to be unsatisfactory because of rapid dispersion into tissues. Early attempts at
needle localization using heavy gauge wires was unsuccessful.
In 1976 the use of single fine hooked wire mammographic localization was first repoited. This
technique with minor modification has superseded other forms of localization and has allowed accurate
biopsy of virtually any non-palpable lesion in the breast4. We report a retrospective review of’ our
experience with needle localization biopsy of 33 marnmographically detected abnormalities in 32
women undergoing mammography for screening or for symptomatic disease.
Patients and Methods 
Case reports of all patients undergoing excision biopsy of breast lesions between January 1989 to
Februaiy 1992 were retrospectively reviewed. Patients with a single non-palpable maminographic
abnormality consisting of either a mass, an abnormal parenchymal density or microcalcification
deemed suspicious for a carcinoma by a radiologist, were considered for mammographic needle
localization and biopsy. Needle hooked wire biopsies were performed upon on an out-patient basis
under general anaesthesia. The following data was reviewed: Age, risk factors, indications for
mammography biopsy, mentgenographic findings of mammography, result of the specimen radiology,
histological diagnosis and complications of the procedure. For patients with carcinoma nodal status,
estrogen receptor status and the final treatment modalities were also reviewed.
Lesions were re-identified on a pre-op mediolateral mammogram. The abnormality was localized with
a Kopans needle, repeat craniocaudal and mediolateral films were used to confirm satisfactory position
of the needle. A fine self-retaining stainless steel hooked wire was then inserted through the needle. The
introducing needle was withdrawn, while the wire existing through the skin of the breast was carefully
secured to prevent dislodgement. The patient with accompanying mammogram was transported to the
operating room for open biopsy. A cylinder of mammary tissue guided by the hooked wire was excised.
Excised lesions specially containing microcalcifications were subjected to specimen radiology to
ensure complete excision. Permanent histological sections were prepared on all specimens from biopsy
and formed the basis for final diagnosis.
Treatment strategy was planned taking into consideration the indication of biopsy, histological finding,
evaluation of remainder of breast tissue and the patients own perception of treatment risks and
outcome.
Results 
Thirty three consecutive needle localization biopsies were performed upon 32 women during a three
year penod. Patients ranged in age from 28 to 73 years (Mean 47.5 years). Mean age at menarche was
12.9 years. Six patients (18.2%) had a positive family histoiy in first degree relatives of malignant
breast diseases.
Fifteen of the patients were postmenopausal (45.5%) and 18 were premenopausal (54.5%). Seven
patients were nulliparous (2 1.2%). Average age at first delivery was 24.7 years. Five patients had
received prior hormonal treatment (oral contraceptives) and none of them had previous breast
irradiation. Ten patients (30.3%) had disease in the opposite breast out of which five were benign and
five were malignant. These five patients were previously diagnosed to have malignant lumps in the
contralatera breast and were treated with mastectomy and/or adjuvant therapy. None of the four patients
with malignant disease in the present series, had malignant disease in the contralateral breast. Except
for two patients (6. 1%) who hadahistoiy offibroids, none of them had any other neoplastic lesion.
Jndications for mammography are represented in Table I.
Table II summarizes the radiological indications for biopsy. Specimen radiology was performed upon
all patients, 90.9% of the specimen radiology confirmed the presence of the original lesion. In
remaining biopsies excisions were completed with further excision.
Benign disease was found in 29 (87.87%) patients and malignancy was demonstrated in 4 (12.12%).
The most common benign lesion was fibrocystic disease without epithelial proliferation. The
histological characteristics of benign and malignant lesion are summarized in Table III.
Comparison of the mammographic findings with the histological findings in the ipsilateral breast
revealed that micro calcification alone accounted for 50% of malignant lesions, whereas both
microcalcification and density accounted for 50% of malignant and 17.24% of the benign lesions.
Nodal involvement was subsequently assessed in all four patients with malignant breast lesion and was
found to be negative in three patients. No patient had evidence of distant metastasis on further studies.
All four were positive for estrogen receptors (50% were intermediately positive and 50% strongly
positive). Treatment options were discussed with the patients. One patient previously treated for
malignant lesion with breast conservation was advised modified radical mastectomy. Two patients
opted for modified radical mastectomy, whereas one patient preferred simple mastectomy. Two patients
were offered further hormonal treatment. One patient with positive lymph nodes received
chemotherapy (Table IV).
Cost analysis for mammography, needle guided biopsy, histological evaluation, anesthesia and
operating room cost as well as the fees of the surgeon wascarried out. The cost of the average combined
procedure performed under local anesthesia was not significantly different from that under general
anesthesia. All costs were calculated with the procedure performed on an out- patient basis.
Discussion 
“Any form of local treatment must depend on its success primarily on early diagnosis” Keynes 19321.
Awareness that an improved prognosis is linked with early breast carcinoma has advocated an
aggressive attitude towards early identification and treatment of this malignancy3. Considerable
experience and data obtained from large scale screening programmes, reveals that many patients will
demonstrate mammographic abnormalities without a clinically palpable mass4. A significant percentage
of these may prove tobe a carcinoma. Mammographic predictor of malignant disease is not sufficiently
sensitive or specific to be relied on to confirm carcinoma. Tissue diagnosis remains the gold standard.
Blind biopsies of non-palpable lesions of the breast was previously performed with considerable
difficulty, inaccuracy and disfigurement to the patient. Likewise, the use of vital dyes and
roentgenographic contrast was similarly unsatisfactory.
The results of published studies have shown that 7 to 33% of patients undergoingMNL are found to
have “minimal” carcinoma of the breast4-12. Given the proportion of patients studied with non invasive
carcinoma of the breast with predominantly node negative stage, our experience is comparable and
acceptable with results of other workers. A generally accepted benign to malignant ratio for biopsies
performed on the basis of clinical findings alone is variable 3:1, 9:1. A benign to malignant ratio of 2-
4:1 reflects accurate radiologic criteria for biopsy without a plethora of unnecessaiy biopsies for
suspicious mammographic findings13-15. Ciatto et al reported abenignto malignant ratio that ranged
from 2.4:1 to 7.3:114 Choucair et al16 found complete agreement in only 16% of 103 mammographic
abnormalities.
The ideal benign to malignant ratio has not been established17,18. We obtained a B:M ratio of 7.25:1.
Five patients were found to have severe fibrocystic changes on biopsy described,as epithelial
hyperplasia with atypia. Although such a pathological diagnosis is classified as benign a recent
consensus opinion places the risk of developing carcinoma of the breast with this lesion as five times
that of the normal population4. This group of women once identified should benefit from more
intensive follow-up.
Documentation of satisfactory excision of the localized abnormality is of paramount importance. This
is usually accomplished with specimen radiology. Microcalcification are generally easily detected by
specimen radiology and thus provide an excellent indicator of adequate excision4. In this study
specimen radiology was used in all the patients. The presence of either microcalcification ormasses was
confirmed in 90.9% of the specimen.
Progress in roentgenographic techniques and development and refinement of MNL for clinically occult
lesions of the breast has led to an increased percentage of positive findings from biopsy and a greater
uniformity of technique amongst investigators. For effective outcome MNL requires timely
coordination between the radiologists, surgeons and pathologists. With proper planning the exercise can
be carried out efficiently on an out-patient basis and at a reasonable cost.
MNL was introduced in Pakistan at the Aga Khan University Hospital in January, 1989. Most of the
patients attending the breast clinic in AKUH are symptomatic with a palpable abnormality with a small
number attending for screening purposes only. These two reasons explain our small study population
of33 needle localization over three years.
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